Barry Zingman is an Infectious Disease physician affiliated with Albert Einstein College of Medicine. OpenAlex indexes 87 publications with 11,288 citations (h-index 24).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingIndustry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
3 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
41.8%Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor13%Descovy45%Triumeq35%Zidovudine20%Part D<11 patientsHuman Immunodeficiency Virus Integrase Strand Transfer Inhibitor11.9%Tivicay100%Part D<11 patients+ 4 more classes in this area
Cardiovascular
32.5%Statin9.1%Atorvastatin Calcium100%Part D≥11 patientsThiazide diuretic7.1%Hydrochlorothiazide100%Part D<11 patients+ 3 more classes in this area
Nervous system
11.5%Gabapentinoids4.8%Gabapentin100%Part D<11 patientsNonsteroidal Anti-inflammatory Drug4.3%Ibuprofen100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2016–2017 per NIH RePORTER. The latest:
- Intervention to increase access to PEP to prevent HIV infection among Black MSM
City College of New York
FY2017$210,800R21AI122996 - Intervention to increase access to PEP to prevent HIV infection among Black MSM
City College of New York
FY2016$255,459R21AI122996
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Lipton, MD
Albert Einstein College of Medicine
Marina Konopleva, MD, PhD
Albert Einstein College of Medicine
Joshua Nosanchuk, MD
Albert Einstein College of Medicine
Lawrence Brandt, MD
Albert Einstein College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”